Dobson et al., 2016 - Google Patents
Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivoDobson et al., 2016
View HTML- Document ID
- 8725966169717244298
- Author
- Dobson C
- Devine P
- Phillips J
- Higazi D
- Lloyd C
- Popovic B
- Arnold J
- Buchanan A
- Lewis A
- Goodman J
- Van Der Walle C
- Thornton P
- Vinall L
- Lowne D
- Aagaard A
- Olsson L
- Ridderstad Wollberg A
- Welsh F
- Karamanos T
- Pashley C
- Iadanza M
- Ranson N
- Ashcroft A
- Kippen A
- Vaughan T
- Radford S
- Lowe D
- Publication year
- Publication venue
- Scientific reports
External Links
Snippet
Uncontrolled self-association is a major challenge in the exploitation of proteins as therapeutics. Here we describe the development of a structural proteomics approach to identify the amino acids responsible for aberrant self-association of monoclonal antibodies …
- 241000282414 Homo sapiens 0 title abstract description 27
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dobson et al. | Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo | |
| Zheng et al. | Protein dynamics and conformational changes explored by hydrogen/deuterium exchange mass spectrometry | |
| Deng et al. | Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development–A review | |
| Datta-Mannan et al. | Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics | |
| Hernandez-Alba et al. | Native mass spectrometry, ion mobility, and collision-induced unfolding for conformational characterization of IgG4 monoclonal antibodies | |
| Zhang et al. | Physicochemical rules for identifying monoclonal antibodies with drug-like specificity | |
| Zhang et al. | Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody | |
| Debaene et al. | Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and “bispecific” monoclonal antibody formation | |
| Coales et al. | Epitope mapping by amide hydrogen/deuterium exchange coupled with immobilization of antibody, on‐line proteolysis, liquid chromatography and mass spectrometry | |
| Jones et al. | Complementary MS methods assist conformational characterization of antibodies with altered S–S bonding networks | |
| Cunningham et al. | Polyreactivity and polyspecificity in therapeutic antibody development: risk factors for failure in preclinical and clinical development campaigns | |
| Adams et al. | Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein: protein interaction and modulates its downstream signaling | |
| Trabjerg et al. | Conformational analysis of large and highly disulfide-stabilized proteins by integrating online electrochemical reduction into an optimized H/D exchange mass spectrometry workflow | |
| Pan et al. | Subzero temperature chromatography and top-down mass spectrometry for protein higher-order structure characterization: method validation and application to therapeutic antibodies | |
| Zhang et al. | Structural and functional characterization of a hole–hole homodimer variant in a “knob-into-hole” bispecific antibody | |
| Cornwell et al. | Long-range conformational changes in monoclonal antibodies revealed using FPOP-LC-MS/MS | |
| Pan et al. | Fast comparative structural characterization of intact therapeutic antibodies using hydrogen–deuterium exchange and electron transfer dissociation | |
| Vallejo et al. | Ion mobility–mass spectrometry reveals the structures and stabilities of biotherapeutic antibody aggregates | |
| Liu et al. | IgG2 disulfide isoform conversion kinetics | |
| Voynov et al. | Dynamic fluctuations of protein-carbohydrate interactions promote protein aggregation | |
| Marino et al. | Emerging technologies to assess the higher order structure of monoclonal antibodies | |
| Mock et al. | Development of in silico models to predict viscosity and mouse clearance using a comprehensive analytical data set collected on 83 scaffold-consistent monoclonal antibodies | |
| Guttman et al. | The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8 | |
| Qu et al. | Analysis of binding modes of antigen–antibody complexes by molecular mechanics calculation | |
| DiCara et al. | High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutants |